The Ibovespa slowed its rise in this session and was up 0.14%, at 169,541.27 points, after hitting 170,978.12 points (+0.99%) in the previous update. Among individual highlights, Azevedo & Travassos (AZEV3) extended its gains and was up 29.83%, trading at R$11.36. On the other end, Paranapanema (PMAM3) remained the biggest decliner of the session, down 12.00%, at R$0.22.

Biggest gainers

  • AZEV3 (Azevedo & Travassos): R$11.36 | +29.83%
  • LJQQ3 (Lojas Quero-Quero): R$1.12 | +15.46%
  • HAPV3 (Hapvida): R$5.90 | +8.46%
  • PCAR3 (Grupo Pão de Açucar - GPA): R$2.81 | +8.08%
  • CSNA3 (Companhia Siderúrgica Nacional - CSN): R$3.86 | +4.89%

AZEV3 came from gains of 23.54% and 18.40% in the previous publications and is now close to 30%. The company reported a loss of R$310.3 million in 3Q26, with net revenue of R$204.8 million, up 76.4% from 3Q25, and backlog (contracted revenue pipeline) of R$3.3 billion. LJQQ3 rose 15.46%, above the 13.40% of the previous update. HAPV3 gained 8.46%; Hapvida posted a loss of R$118.8 million in 3Q26, with net revenue of R$8.1 billion. PCAR3 rose 8.08%, and CSNA3, 4.89%.

Biggest decliners

  • PMAM3 (Paranapanema): R$0.22 | -12.00%
  • BAZA3 (Banco da Amazônia): R$59.62 | -6.51%
  • PDGR3 (PDG Realty): R$0.16 | -5.88%
  • ONCO3 (Oncoclínicas): R$0.73 | -5.19%
  • GFSA3 (Gafisa): R$0.20 | -4.76%

PMAM3 maintains the 12.00% drop recorded in the first publication of the session. Paranapanema set the conversion of debentures (debt securities) at R$0.22 per share, a price valid from 11/10 to 12/24/2026. BAZA3 fell 6.51%, after a 6.38% drop in the previous update. PDGR3 dropped 5.88%, ONCO3, 5.19%, and GFSA3, 4.76%. Oncoclínicas postponed the release of its 3Q26 ITR (Quarterly Information), with an estimated deadline in the third week of December.

Also read:

For information only; not investment advice.